Richard Vines: An update on the work of Rare Cancers Australia in Asia

Richard Vines, Chair – Rare Cancers Australia, made the following post on LinkedIn:     .

“An update on the work of Rare Cancers Australia in Asia.”

Quoting Herbert Loong reshared the post and added the following:

“Thanks Richard Vines and Rare Cancers Australia for organising this workshop. I believe there is a lot of synergism that can be cultivated in patients advocacy in the AsiaPacific region. Happy to take part and support these endeavours.”

Read further.
Source: Richard Vines/LinkedIn and Herbert Loong/LinkedIn

Dr. Herbert H. F. Loong is an Associate Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong (CUHK), with additional roles as Deputy Medical Director of the Phase 1 Clinical Trials Centre and founder of the Prince of Wales Hospital Adult Sarcoma Multidisciplinary Team.

Dr. Loong has co-founded key organizations like the Asia Pacific Oncology Drug Development Consortium (APODDC) and the Asia Pacific Coalition Against Lung Cancer (APCLC). His involvement in international oncology bodies, including ASCO and IASLC, underscores his commitment to advancing cancer research and treatment on a global scale.